[go: up one dir, main page]

EE200200168A - PRV-1 gene and its use - Google Patents

PRV-1 gene and its use

Info

Publication number
EE200200168A
EE200200168A EEP200200168A EEP200200168A EE200200168A EE 200200168 A EE200200168 A EE 200200168A EE P200200168 A EEP200200168 A EE P200200168A EE P200200168 A EEP200200168 A EE P200200168A EE 200200168 A EE200200168 A EE 200200168A
Authority
EE
Estonia
Prior art keywords
prv
gene
Prior art date
Application number
EEP200200168A
Other languages
Estonian (et)
Inventor
Pahl Heike
Original Assignee
Universittsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universittsklinikum Freiburg filed Critical Universittsklinikum Freiburg
Publication of EE200200168A publication Critical patent/EE200200168A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP200200168A 1999-09-30 2000-09-29 PRV-1 gene and its use EE200200168A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (en) 1999-09-30 1999-09-30 The PRV-1 gene and its use
PCT/EP2000/009594 WO2001023554A1 (en) 1999-09-30 2000-09-29 The prv-1 gene and use thereof

Publications (1)

Publication Number Publication Date
EE200200168A true EE200200168A (en) 2003-04-15

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200168A EE200200168A (en) 1999-09-30 2000-09-29 PRV-1 gene and its use

Country Status (21)

Country Link
EP (1) EP1220920A1 (en)
JP (1) JP2003510077A (en)
KR (1) KR20020047191A (en)
CN (1) CN1377408A (en)
AU (1) AU1132401A (en)
BG (1) BG106554A (en)
BR (1) BR0014444A (en)
CA (1) CA2387702A1 (en)
CZ (1) CZ20021094A3 (en)
DE (1) DE19947010A1 (en)
EA (1) EA200200286A1 (en)
EE (1) EE200200168A (en)
HR (1) HRP20020269A2 (en)
HU (1) HUP0203080A2 (en)
IL (1) IL148770A0 (en)
MX (1) MXPA02002800A (en)
NO (1) NO20021498L (en)
PL (1) PL354184A1 (en)
SK (1) SK4262002A3 (en)
WO (1) WO2001023554A1 (en)
ZA (1) ZA200202379B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
EA201491920A1 (en) 2012-05-21 2016-03-31 Дженентек, Инк. WAYS TO IMPROVE SECURITY OF TRANSPORT THROUGH HEMATOENCEPHALIC BARRIER
WO2018229179A1 (en) * 2017-06-14 2018-12-20 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (en) * 1998-10-23 2000-04-27 Univ Ludwigs Albert New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
CA2348757A1 (en) * 1998-12-16 2000-06-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
HUP0203080A2 (en) 2002-12-28
HRP20020269A2 (en) 2003-06-30
ZA200202379B (en) 2003-10-29
JP2003510077A (en) 2003-03-18
MXPA02002800A (en) 2002-07-22
CZ20021094A3 (en) 2002-06-12
NO20021498D0 (en) 2002-03-26
KR20020047191A (en) 2002-06-21
EP1220920A1 (en) 2002-07-10
NO20021498L (en) 2002-05-23
CA2387702A1 (en) 2001-04-05
SK4262002A3 (en) 2002-09-10
DE19947010A1 (en) 2001-04-05
WO2001023554A1 (en) 2001-04-05
BR0014444A (en) 2002-06-11
EA200200286A1 (en) 2002-12-26
CN1377408A (en) 2002-10-30
IL148770A0 (en) 2002-09-12
PL354184A1 (en) 2003-12-29
BG106554A (en) 2003-01-31
AU1132401A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
EE05169B1 (en) Substituted oxazolidinones and their uses
EE04452B1 (en) Pharmaceutically Active Morpholinol and Its Use
EE200200251A (en) Novel N-azabicycloamide derivatives and their use
EE05210B1 (en) Antidiabetic agent and its use in medicine
ID26389A (en) DIAPON ONCE USE
EE200200175A (en) Substituted 2-Thio-3,5-Dicyano-4-aryl-6-aminopyridines and their Uses
EE200100373A (en) Benzoheterocycles and their use as MEK inhibitors
ID26599A (en) TRIAZOLA AND IMIDAZOLA DOWN
DE60032898D1 (en) ARYLTHIAZOLIDEINDION AND ARYLOXAZOLIDINE DERIVATIVES
DE60014955D1 (en) Spanner
EE200200282A (en) Chemical methods and intermediates
ID25571A (en) DIAPON ONCE USE
ID24782A (en) DIAPON ONCE USE
EP1210084A4 (en) PYRIDOMORPHINANES, THIENOMORPHINANES AND USE
NO20021604L (en) Leptin assay
NO20021305L (en) DNA construction and its use
EE200200096A (en) IREN protein, its preparation and use
EE200200168A (en) PRV-1 gene and its use
ID25567A (en) SCREW-CLOSED WITH SHOULDER-TWIN
EE200200353A (en) Human heparanase-like polypeptide and nucleic acid
EP1417218A4 (en) METALLOTHIONEIN-TETRAHYMENA GENE PROMOTER AND USE THEREOF
EP1241256A4 (en) NEW GENE AND USE
FI980680L (en) Structure and its use
NO20015906D0 (en) Spliceosome protein and its use
SE9903962D0 (en) New use